Philippines OKs Merck's COVID-19 pill for at-risk patients

seekingalpha2021-12-23

The Philippines has approved emergency use of Merck's(NYSE:MRK)COVID-19 treatment pill for adult patients at risk of developing severe illness -Reuters. It also approved the Pfizer(NYSE:PFE)- BioNTech...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Baby Step 4
2021-12-24
Baby Step 4
Amazing
LIM97
2021-12-23
LIM97
ok
Yeeshen
2021-12-23
Yeeshen
Gg
- LIM97:
  ok
Ahwei6868
2021-12-23
Ahwei6868
Ok
moonlightbae
2021-12-23
moonlightbae
Pog
trevor89
2021-12-23
trevor89
Nice

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1150425511?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-12-23 19:33","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1150425511","market":"us","top_or_hot":-1,"title":"Philippines OKs Merck's COVID-19 pill for at-risk patients","media":"seekingalpha","content":"<div>\n<p>The Philippines has approved emergency use of Merck's(NYSE:MRK)COVID-19 treatment pill for adult patients at risk of developing severe illness -Reuters.\nIt also approved the Pfizer(NYSE:PFE)- BioNTech...</p>\n\n<a href=\"https://seekingalpha.com/news/3782924-philippines-oks-mercks-covid-19-pill-for-at-risk-patients-reuters\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Philippines OKs Merck's COVID-19 pill for at-risk patients</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPhilippines OKs Merck's COVID-19 pill for at-risk patients\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 19:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3782924-philippines-oks-mercks-covid-19-pill-for-at-risk-patients-reuters><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Philippines has approved emergency use of Merck's(NYSE:MRK)COVID-19 treatment pill for adult patients at risk of developing severe illness -Reuters.\nIt also approved the Pfizer(NYSE:PFE)- BioNTech...</p>\n\n<a href=\"https://seekingalpha.com/news/3782924-philippines-oks-mercks-covid-19-pill-for-at-risk-patients-reuters\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRK","symbol_name":"默沙东","start_time":0,"source_url":"https://seekingalpha.com/news/3782924-philippines-oks-mercks-covid-19-pill-for-at-risk-patients-reuters","article_id":"1150425511","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150425511","pubTimestamp":1640259222,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"The Philippines has approved emergency use of Merck's(NYSE:MRK)COVID-19 treatment pill for adult pat","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRK":"默沙东"},"translate_title":"菲为高危患者研制默沙东新冠肺炎药丸","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRK":0.9},"content_text":"The Philippines has approved emergency use of Merck's(NYSE:MRK)COVID-19 treatment pill for adult patients at risk of developing severe illness -Reuters.\nIt also approved the Pfizer(NYSE:PFE)- BioNTech's(NASDAQ:BNTX)COVID-19 vaccine for children aged 5-11 so the vaccine, which will be administered in a pediatric formulation.\nPhilippines FDA chief Rolando Enrique Domingo told the benefits outweighed the risks and it was already being used for children in countries likeU.S. and Canada.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9000722324,"gmtCreate":1640314942864,"gmtModify":1676533516162,"author":{"id":"3585617155516823","authorId":"3585617155516823","name":"Baby Step 4","avatar":"https://static.tigerbbs.com/8ee1c9c06b2929c88e9f5bb3a24cf2d2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3585617155516823","idStr":"3585617155516823"},"htmlText":"Amazing&nbsp;","listText":"Amazing&nbsp;","text":"Amazing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000722324","repostId":1150425511,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9000460413,"gmtCreate":1640265363156,"gmtModify":1676533513042,"author":{"id":"3581419265926610","authorId":"3581419265926610","name":"LIM97","avatar":"https://static.tigerbbs.com/6e8b924a13e75ddd5dcb294949bced1f","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581419265926610","idStr":"3581419265926610"},"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000460413","repostId":1150425511,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":698061724,"gmtCreate":1640264340663,"gmtModify":1676532435187,"author":{"id":"3557700781666328","authorId":"3557700781666328","name":"Yeeshen","avatar":"https://community-static.tradeup.com/news/1dad2b70e40d5458fc62d9829e69da43","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3557700781666328","idStr":"3557700781666328"},"htmlText":"Gg","listText":"Gg","text":"Gg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/698061724","repostId":1150425511,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":100022790,"gmtCreate":1640265383737,"gmtModify":1663241503638,"authorId":3581419265926610,"author":{"id":3581419265926610,"idStr":"3581419265926610","authorId":3581419265926610,"name":"LIM97","avatar":"https://static.tigerbbs.com/6e8b924a13e75ddd5dcb294949bced1f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":698061724,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"CN"},{"id":9000483852,"gmtCreate":1640262621257,"gmtModify":1676533512828,"author":{"id":"3576210449115034","authorId":"3576210449115034","name":"Ahwei6868","avatar":"https://static.tigerbbs.com/1fd3c758c9658a33289fa552d6d0f3d2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3576210449115034","idStr":"3576210449115034"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000483852","repostId":1150425511,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":698081711,"gmtCreate":1640262172046,"gmtModify":1676532434872,"author":{"id":"3575016656391852","authorId":"3575016656391852","name":"moonlightbae","avatar":"https://static.tigerbbs.com/9e8bead30ce122327046cb50ca725a77","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3575016656391852","idStr":"3575016656391852"},"htmlText":"Pog","listText":"Pog","text":"Pog","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/698081711","repostId":1150425511,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":9000414553,"gmtCreate":1640260844177,"gmtModify":1676533512734,"author":{"id":"3549929450481635","authorId":"3549929450481635","name":"trevor89","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3549929450481635","idStr":"3549929450481635"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000414553","repostId":1150425511,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":60,"commentSize":14,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1150425511"}